Skip to main content
. 2016 Oct 1;7(47):76667–76683. doi: 10.18632/oncotarget.12395

Table 2. Sequences of the primers used in the present study.

Primer Sequence 5′→3′
miR-22 stem-loop primer GTCGTATCCAGTGCAGGGTCCGAGGTATTCGCACTGGATACGACACAGTT
miR-22-F AAGCTGCCAGTTGAAGAACTGT
Universal reverse primer GTGCAGGGTCCGAGGT
pri-miR-22-F AGGAGTAGAAGGCTCAAACA
pri-miR-22-R AGGAGGGTCAAGAAGGAA
pre-miR-22-F GGCGAGCCGCAGAGC
pre-miR-22-R GGCGGGGCCGTTCTT
hCCL5-F CTGTCATCCTCATTGCTACTGC
hCCL5-R ATGTACTCCCGAACCCATTTCT
hIFN-β-F TTCCCAGGGCTTACACCG
hIFN-β-R TAACCCAAGTTCCCGAGT
hMAVS-3′-UTR-XhoI-F ACGCTCGAGAGCCCAGCCTGAGACCGT
hMAVS-3′-UTR-PmeI-R CGGTTTAAACCTGCACCCTTGACCACTGTG
Mutant-primer-2-R CTGACACGACCCCCTGGC
Mutant-primer-3-F AGCCAGGGGGTCGTGTC
hMAVS-KpnI-F CGAGGTACC ATGCCGTTTGCTGAAGACAAGACC
hMAVS-XhoI-R ACGCTCGAGGTGCAGACGCCGCCGGT

h: human.